Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Ryan Allway July 30th, 2021 Psychedelics Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company completed its acquisition... Read more
Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.
Ryan Allway June 16th, 2021 Psychedelics Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols Vancouver, British Columbia–(Newsfile Corp. – June 16, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company has entered into... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )